Reporter
Vanderbilt study links gene expression, disease association data
Jul. 27, 2018—An international team of researchers led by Eric Gamazon has integrated gene expression and disease association data to better understand the biological mechanisms of complex human diseases.
Fueling the MATE transporter
Jul. 20, 2018—In new research, Hassane Mchaourab and colleagues have uncovered new insights into drug resistance that could lead to the development of new anti-cancer and antibacterial drugs.
Team finds potent antibodies against three Ebola viruses
Jul. 19, 2018—Researchers led by James Crowe Jr. are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans. The hope is that the antibodies — like heat-seeking missiles — would seek out and destroy the viruses before they can wreak havoc in the body.
Study reveals opioid patients face multiple barriers to treatment
Jul. 12, 2018—In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.
Team explores diabetes drug’s ability to treat RSV infection
Jul. 12, 2018—A drug used to treat diabetes, liraglutide, may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways.
SMAD4 clue to colon cancer
Jul. 5, 2018—Chronic inflammation is a predisposing condition for colorectal cancer, the third leading cause of cancer-related deaths in the United States. Anna Means, Ph.D., and colleagues have now linked inflammation-driven carcinogenesis in the colon to loss of an important signaling protein called SMAD4.
Vanderbilt recognized again for cancer prevention activities
Jun. 19, 2014—Vanderbilt continues to win recognition for its commitment to helping employees stay healthy, including support for activities that may protect against cancer. Vanderbilt University Medical Center (VUMC), in conjunction with Vanderbilt-Ingram Cancer Center (VICC), has been re-accredited as a CEO Cancer Gold Standard employer for 2014. In 2001, former President George H.W. Bush asked a...
